{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T14:48:01Z","timestamp":1776091681824,"version":"3.50.1"},"reference-count":50,"publisher":"MJS Publishing, Medical Journals Sweden AB","license":[{"start":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T00:00:00Z","timestamp":1776038400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AO"],"abstract":"<jats:p>ABSTRACTBackground and purpose: Pancreatic cancer is difficult to diagnose early and at a curative stage, yet little is known about errors in management. The aim of the study was to investigate malpractice claims in Norway. Patients and Methods: All malpractice claims filed to the Norwegian System of Patient Injury Compensation between 2015 and 2024 for pancreatic cancer were evaluated.Results: A total of 148 claims (median 15 [range 8\u201320] claims\/year) were filed among 9548 patients with pancreatic cancer, for an average claim rate of 1.55% (1 claim per every 65 pancreatic cancers). Most claims were filed against hospital\/specialists (n = 90), followed by general practitioners (n = 49) with nine claims towards private practice contractors (P &lt; 0.001). A total of 33 claims (22.3%) were approved, of which 28 (85%) concerned delayed diagnosis. Radiology was involved in 18 of the 33 approvals. According to caretaker-level for the malpractice claim, approved claims were 23% for hospital-claims, with lowest approval-rate against general practitioners (12%), and highest against private contractors (66%). Median delay in diagnosis was estimated at 6 months. The outcome of the error was \u2018death\u2019 in 16 of 33. Prognostic loss was determined in five of 33 patients, while 12 patients had no prognostic loss despite an approved claim. Caretaker-level did not differ regarding death or prognostic loss in claims (P = 0.203). A total of 1.47 million EUR was paid in indemnity payments.Interpretation: The claim rate of 1.5% was stable, with about one in five claims approved. Diagnostic delay was the predominant cause, with several stakeholders involved across the healthcare system.<\/jats:p>","DOI":"10.2340\/ao.v65.45500","type":"journal-article","created":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T13:47:36Z","timestamp":1776088056000},"page":"273-281","source":"Crossref","is-referenced-by-count":0,"title":["Malpractice claims for pancreatic cancer in Norway: claim-rates, injury domains, claim outcomes and indemnity compensation"],"prefix":"10.2340","volume":"65","author":[{"given":"Annbj\u00f8rg H","family":"S\u00f8reide","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karin H.","family":"Edland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas B.","family":"Alvestad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Solveig","family":"Hodne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7594-4354","authenticated-orcid":false,"given":"Kjetil","family":"S\u00f8reide","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1183","published-online":{"date-parts":[[2026,4,13]]},"reference":[{"key":"149098","doi-asserted-by":"crossref","unstructured":"Mannucci A, Goel A. Advances in pancreatic cancer early diagnosis, prevention, and treatment: the past, the present, and the future. CA Cancer J Clin. 2026;76(1):e70035.","DOI":"10.3322\/caac.70035"},{"key":"149099","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.3322\/caac.70035","DOI":"10.3322\/caac.70035"},{"key":"149100","unstructured":"GBD 2017 Pancreatic Cancer Collaborators. The global, regional, and national burden of pancreatic cancer and its attributable risk factors in 195 countries and territories, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol. 2019;4(12):934\u201347."},{"key":"149101","doi-asserted-by":"crossref","unstructured":"Shen MJ, Jamali A, Katona BW. Challenges of early detection of pancreatic cancer. J Clin Invest. 2025 Oct 15;135(20):e191942.","DOI":"10.1172\/JCI191942"},{"key":"149102","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1172\/JCI191942","DOI":"10.1172\/JCI191942"},{"key":"149103","doi-asserted-by":"crossref","unstructured":"Conroy T, Pfeiffer P, Vilgrain V, Lamarca A, Seufferlein T, O\u2019Reilly EM, et al. Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol. 2023;34(11):987\u20131002.","DOI":"10.1016\/j.annonc.2023.08.009"},{"key":"149104","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.annonc.2023.08.009","DOI":"10.1016\/j.annonc.2023.08.009"},{"key":"149105","doi-asserted-by":"crossref","unstructured":"S\u00f8reide K, Rangelova E, Dopazo C, Mieog S, St\u00e4ttner S. Pancreatic cancer. Eur J Surg Oncol. 2023;49(2):521\u20135.","DOI":"10.1016\/j.ejso.2023.01.001"},{"key":"149106","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.ejso.2023.01.001","DOI":"10.1016\/j.ejso.2023.01.001"},{"key":"149107","unstructured":"Olakotan O, Yargawa J, Moreland JA, Friedemann Smith C,"},{"key":"149108","doi-asserted-by":"crossref","unstructured":"Nicholson BD, Millar A, et al. Characteristics of optimal cancer referrals made by primary care clinicians: scoping review. Cancer Control. 2025;32:10732748251359405.","DOI":"10.1177\/10732748251359405"},{"key":"149109","doi-asserted-by":"crossref","unstructured":"Black GB, Nicholson BD, Moreland JA, Fulop NJ, Lyratzopoulos G, Baxter R. Doing \u2018detective work\u2019 to find a cancer: how are non-specific symptom pathways for cancer investigation organised, and what are the implications for safety and quality of care? A multisite qualitative approach. BMJ Qual Saf. 2025;34(7):457\u201368.","DOI":"10.1136\/bmjqs-2024-017749"},{"key":"149110","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1136\/bmjqs-2024-017749","DOI":"10.1136\/bmjqs-2024-017749"},{"key":"149111","doi-asserted-by":"crossref","unstructured":"van Dongen JC, van der Geest LGM, de Meijer VE, van Santvoort HC, de Vos-Geelen J, Besselink MG, et al. Age and prognosis in patients with pancreatic cancer: a population-based study. Acta Oncol. 2022;61(3):286\u201393.","DOI":"10.1080\/0284186X.2021.2016949"},{"key":"149112","doi-asserted-by":"crossref","unstructured":"Singh H, Sethi S, Raber M, Petersen LA. Errors in cancer diagnosis: current understanding and future directions. J Clin Oncol. 2007;25(31):5009\u201318.","DOI":"10.1200\/JCO.2007.13.2142"},{"key":"149113","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1200\/JCO.2007.13.2142","DOI":"10.1200\/JCO.2007.13.2142"},{"key":"149114","doi-asserted-by":"crossref","unstructured":"Ravlo M, Lieng M, Khan Bukholm IR, Haase Moen M, Vanky E. Claims for compensation from women with cervical cancer in Norway \u2013 a retrospective, descriptive study of a 12-year period. Acta Obstet Gynecol Scand. 2020;99(11):1546\u201353.","DOI":"10.1111\/aogs.13930"},{"key":"149115","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/aogs.13930","DOI":"10.1111\/aogs.13930"},{"key":"149116","doi-asserted-by":"crossref","unstructured":"Hafstr\u00f6m L, Johansson H, Ahlberg J. Does diagnostic delay of colorectal cancer result in malpractice claims? A retrospective analysis of the Swedish board of malpractice from 1995\u20132008. Patient Saf Surg. 2012;6(1):13.","DOI":"10.1186\/1754-9493-6-13"},{"key":"149117","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1186\/1754-9493-6-13","DOI":"10.1186\/1754-9493-6-13"},{"key":"149118","doi-asserted-by":"crossref","unstructured":"Doolin JW, Schaffer AC, Tishler RB, Jacobson JO. An analysis of medical malpractice claims against medical oncologists from a national database: implications for safer practice. J Healthc Risk Manag. 2024;43(3):18\u201328.","DOI":"10.1002\/jhrm.21563"},{"key":"149119","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1002\/jhrm.21563","DOI":"10.1002\/jhrm.21563"},{"key":"149120","unstructured":"Chang S, Daskivich TJ, Vasquez M, Sacks WL, Zumsteg ZS,"},{"key":"149121","unstructured":"Ho AS. Malpractice trends involving active surveillance across"},{"key":"149122","doi-asserted-by":"crossref","unstructured":"cancers. Ann Surg. 2024;279(4):679\u201383.","DOI":"10.1097\/SLA.0000000000006101"},{"key":"149123","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1097\/SLA.0000000000006101","DOI":"10.1097\/SLA.0000000000006101"},{"key":"149124","unstructured":"J\u00f8rstad RG. The Norwegian system of compensation to patients. Med Law. 2002;21(4):681\u20136."},{"key":"149125","doi-asserted-by":"crossref","unstructured":"Rosenkrantz AB, Siegal D, Skillings JA, Muellner A, Nass SJ, Hricak H. Oncologic errors in diagnostic radiology: a 10-year analysis based on medical malpractice claims. J Am Coll Radiol. 2021;18(9):1310\u20136.","DOI":"10.1016\/j.jacr.2021.05.001"},{"key":"149126","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.jacr.2021.05.001","DOI":"10.1016\/j.jacr.2021.05.001"},{"key":"149127","doi-asserted-by":"crossref","unstructured":"Mokienko A. Effects of a reimbursement change and travel times on the delivery of private and public radiology services in Norway: a register-based longitudinal study of Norwegian claims data. Cost Eff Resour Alloc. 2019;17:22.","DOI":"10.1186\/s12962-019-0190-7"},{"key":"149128","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1186\/s12962-019-0190-7","DOI":"10.1186\/s12962-019-0190-7"},{"key":"149129","doi-asserted-by":"crossref","unstructured":"Ansari D, S\u00f8reide K, Andersson B, Hansen CP, Sepp\u00e4nen H, Sparrelid E, et al. Surveillance after surgery for pancreatic cancer: a global scoping review of guidelines and a nordic Survey of contemporary practice. Scand J Gastroenterol. 2024;59(9):1097\u2013104.","DOI":"10.1080\/00365521.2024.2378948"},{"key":"149130","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1080\/00365521.2024.2378948","DOI":"10.1080\/00365521.2024.2378948"},{"key":"149131","doi-asserted-by":"crossref","unstructured":"S\u00f8reide K, M\u00f8ller JH, Strand K, S\u00f8reide AH, Hodne S, Karlsen LN. Malpractice and compensation claims for acute pancreatitis in Norway: characteristics of claimants, claim-rates, outcomes and indemnity compensation. Scand J Gastroenterol. 2025;60(10):1032\u201342.","DOI":"10.1080\/00365521.2025.2537280"},{"key":"149132","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1080\/00365521.2025.2537280","DOI":"10.1080\/00365521.2025.2537280"},{"key":"149133","doi-asserted-by":"crossref","unstructured":"Skjold-\u00d8degaard B, Braut GS, Ersdal HL, S\u00f8reide K. Claims filed after perceived malpractice in management of acute appendicitis: an observational nationwide cohort study. Scand J Surg. 2025;114(4):414\u201320.","DOI":"10.1177\/14574969251363823"},{"key":"149134","doi-asserted-by":"crossref","unstructured":"Aae TF, Jakobsen RB, Bukholm IRK, Fenstad AM, Furnes O, Randsborg PH. Compensation claims after hip arthroplasty surgery in Norway 2008\u20132018. Acta Orthop. 2021;92(3):311\u20135.","DOI":"10.1080\/17453674.2021.1872901"},{"key":"149135","unstructured":"https:\/\/doi.org\/10.1080\/"},{"key":"149136","unstructured":"17453674.2021.1872901"},{"key":"149137","doi-asserted-by":"crossref","unstructured":"Holman A, McKeown E, Quinn M, Parikh ND, Tapper EB. Medical malpractice claims in hepatology: rates, reasons, and results. Hepatol Commun. 2023;7(5).","DOI":"10.1097\/HC9.0000000000000122"},{"key":"149138","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1097\/HC9.0000000000000122","DOI":"10.1097\/HC9.0000000000000122"},{"key":"149139","doi-asserted-by":"crossref","unstructured":"Nilbert M. Changing before we have to; how to mitigate disparities in pancreatic cancer care? Acta Oncol. 2022;61(3):275\u20136.","DOI":"10.1080\/0284186X.2022.2041720"},{"key":"149140","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1080\/0284186X.2022.2041720","DOI":"10.1080\/0284186X.2022.2041720"},{"key":"149141","doi-asserted-by":"crossref","unstructured":"S\u00f8reide K, Ismail W, Roals\u00f8 M, Ghotbi J, Zaharia C. Early diagnosis of pancreatic cancer: clinical premonitions, timely precursor detection and increased curative-intent surgery. Cancer Control. 2023;30:10732748231154711.","DOI":"10.1177\/10732748231154711"},{"key":"149142","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1177\/10732748231154711","DOI":"10.1177\/10732748231154711"},{"key":"149143","doi-asserted-by":"crossref","unstructured":"Kulkarni NM, Soloff EV, Tolat PP, Sangster GP, Fleming JB, Brook OR, et al. White paper on pancreatic ductal adenocarcinoma from society of abdominal radiology\u2019s disease-focused panel for pancreatic ductal adenocarcinoma: part I, AJCC staging system, NCCN guidelines, and borderline resectable disease. Abdom Radiol (NY). 2020;45(3):716\u201328.","DOI":"10.1007\/s00261-019-02289-5"},{"key":"149144","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1007\/s00261-019-02289-5","DOI":"10.1007\/s00261-019-02289-5"},{"key":"149145","doi-asserted-by":"crossref","unstructured":"Kohan, A., Grant, R.C., Henault, D. et al. AI-Based Segmentation Reduces the Retrospective Miss Rate of Pancreatic Ductal Adenocarcinoma. J Digit Imaging. Inform. med. (2025). https:\/\/doi.org\/10.1007\/s10278-025-01792-0","DOI":"10.1007\/s10278-025-01792-0"},{"key":"149146","doi-asserted-by":"crossref","unstructured":"Alves N, Schuurmans M, Rutkowski D, Saha A, Vendittelli P, Obuchowski N, et al. Artificial intelligence and radiologists in pancreatic cancer detection using standard of care CT scans (PANORAMA): an international, paired, non-inferiority, confirmatory, observational study. Lancet Oncol. 2026;27(1):116\u201324.","DOI":"10.1016\/S1470-2045(25)00567-4"},{"key":"149147","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/S1470-2045(25)00567-4","DOI":"10.1016\/S1470-2045(25)00567-4"}],"container-title":["Acta Oncologica"],"original-title":[],"link":[{"URL":"https:\/\/medicaljournalssweden.se\/actaoncologica\/article\/download\/45500\/53492","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/medicaljournalssweden.se\/actaoncologica\/article\/download\/45500\/53492","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T13:48:22Z","timestamp":1776088102000},"score":1,"resource":{"primary":{"URL":"https:\/\/medicaljournalssweden.se\/actaoncologica\/article\/view\/45500"}},"subtitle":["Malpractice claims for pancreatic cancer"],"short-title":[],"issued":{"date-parts":[[2026,4,13]]},"references-count":50,"URL":"https:\/\/doi.org\/10.2340\/ao.v65.45500","relation":{},"ISSN":["1651-226X"],"issn-type":[{"value":"1651-226X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,13]]}}}